Vanguard Capital Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.05B Buy
1,928,928
+10,672
+0.6% +$5.52M 0.02% 472
2026
Q2
$1.04B Sell
1,918,256
-39,283
-2% -$22.1M 0.02% 493
2026
Q1
$1.16B Buy
+1,957,539
New +$975M 0.03% 440

Other funds holding UTHR

Vanguard Capital Management's UTHR Position: Q3 2026 in Review

Vanguard Capital Management increased its United Therapeutics (UTHR) stake by 0.56% in Q3 2026, buying an estimated $5.52M and bringing the position to 1,928,928 shares worth $1.05B. The position accounts for 0.02% of the portfolio, ranked #472.

Vanguard Capital Management first reported a position in UTHR in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.16B in Q1 2026. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Vanguard Capital Management held 1,928,928 shares of United Therapeutics worth $1.05B as of Q3 2026.
  • Vanguard Capital Management bought 10,672 United Therapeutics shares in Q3 2026, an estimated $5.52M.
  • United Therapeutics made up 0.02% of Vanguard Capital Management's portfolio in Q3 2026, its #472 holding.
  • Vanguard Capital Management first reported a position in United Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's United Therapeutics position peaked at $1.16B in Q1 2026.
  • 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.